Real-world experience of ozanimod in adults with multiple sclerosis
{{output}}
Aim: Ozanimod is a second-generation sphingosine 1-phosphate receptor (S1PR) modulator approved for treatment of relapsing multiple sclerosis (MS). Data are lacking for ozanimod use in real-world clinical practice. This study aim... ...
